Concepts (257)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Microbiome | 17 | 2023 | 133 | 1.840 |
Why?
|
| Microbiota | 15 | 2024 | 85 | 1.680 |
Why?
|
| Vaginosis, Bacterial | 6 | 2024 | 27 | 1.120 |
Why?
|
| Staphylococcal Infections | 7 | 2022 | 162 | 1.010 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 6 | 2021 | 117 | 0.860 |
Why?
|
| Circadian Rhythm | 5 | 2022 | 220 | 0.640 |
Why?
|
| Feces | 10 | 2023 | 87 | 0.580 |
Why?
|
| Dysbiosis | 5 | 2018 | 40 | 0.500 |
Why?
|
| Oligosaccharides | 3 | 2021 | 12 | 0.490 |
Why?
|
| Inflammation | 4 | 2021 | 226 | 0.460 |
Why?
|
| Cross Infection | 3 | 2025 | 299 | 0.450 |
Why?
|
| Colon | 6 | 2023 | 104 | 0.450 |
Why?
|
| Parkinson Disease | 4 | 2023 | 556 | 0.400 |
Why?
|
| Genomics | 6 | 2025 | 61 | 0.390 |
Why?
|
| Male | 28 | 2025 | 12453 | 0.380 |
Why?
|
| Humans | 37 | 2025 | 22848 | 0.370 |
Why?
|
| Female | 26 | 2025 | 12677 | 0.360 |
Why?
|
| Animals | 14 | 2023 | 3025 | 0.350 |
Why?
|
| Prebiotics | 3 | 2023 | 20 | 0.340 |
Why?
|
| Herpes Genitalis | 2 | 2022 | 4 | 0.340 |
Why?
|
| Sexual and Gender Minorities | 2 | 2021 | 24 | 0.340 |
Why?
|
| Saliva | 2 | 2022 | 44 | 0.330 |
Why?
|
| Eating | 2 | 2021 | 53 | 0.320 |
Why?
|
| Intestines | 3 | 2021 | 73 | 0.310 |
Why?
|
| Food Hypersensitivity | 2 | 2021 | 39 | 0.310 |
Why?
|
| HIV Infections | 2 | 2022 | 369 | 0.300 |
Why?
|
| Starch | 2 | 2019 | 11 | 0.290 |
Why?
|
| RNA, Ribosomal, 16S | 7 | 2024 | 51 | 0.290 |
Why?
|
| Disease Models, Animal | 5 | 2023 | 477 | 0.280 |
Why?
|
| Mice, Inbred C57BL | 8 | 2023 | 343 | 0.280 |
Why?
|
| Dietary Fiber | 2 | 2017 | 26 | 0.270 |
Why?
|
| Vagina | 2 | 2024 | 31 | 0.270 |
Why?
|
| Alcohol Drinking | 2 | 2019 | 65 | 0.270 |
Why?
|
| Milk, Human | 2 | 2019 | 147 | 0.260 |
Why?
|
| Colon, Sigmoid | 2 | 2017 | 13 | 0.250 |
Why?
|
| Sinusitis | 2 | 2018 | 159 | 0.250 |
Why?
|
| Mice | 8 | 2023 | 1128 | 0.240 |
Why?
|
| Menstrual Hygiene Products | 2 | 2023 | 5 | 0.240 |
Why?
|
| Colitis | 2 | 2023 | 28 | 0.240 |
Why?
|
| Herpesvirus 2, Human | 3 | 2022 | 5 | 0.240 |
Why?
|
| Ulcer | 2 | 2017 | 6 | 0.240 |
Why?
|
| Candidiasis | 1 | 2025 | 24 | 0.240 |
Why?
|
| Rain | 1 | 2024 | 2 | 0.230 |
Why?
|
| Toilet Facilities | 1 | 2024 | 2 | 0.230 |
Why?
|
| Bacteria | 3 | 2024 | 57 | 0.230 |
Why?
|
| Immune System | 2 | 2021 | 11 | 0.230 |
Why?
|
| Circumcision, Male | 2 | 2022 | 8 | 0.220 |
Why?
|
| Laboratories, Hospital | 1 | 2024 | 3 | 0.220 |
Why?
|
| Enterobacteriaceae | 2 | 2024 | 44 | 0.220 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2023 | 16 | 0.210 |
Why?
|
| STAT3 Transcription Factor | 1 | 2023 | 11 | 0.200 |
Why?
|
| Community-Acquired Infections | 2 | 2021 | 66 | 0.200 |
Why?
|
| Kenya | 5 | 2023 | 10 | 0.200 |
Why?
|
| Biodiversity | 2 | 2019 | 12 | 0.200 |
Why?
|
| Circumcision, Female | 1 | 2022 | 2 | 0.200 |
Why?
|
| Butyrates | 2 | 2019 | 12 | 0.200 |
Why?
|
| Shift Work Schedule | 1 | 2022 | 8 | 0.190 |
Why?
|
| Mouth | 1 | 2022 | 12 | 0.190 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2021 | 21 | 0.190 |
Why?
|
| Adult | 11 | 2022 | 6584 | 0.190 |
Why?
|
| Dietary Supplements | 1 | 2021 | 54 | 0.190 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2018 | 30 | 0.180 |
Why?
|
| Universities | 1 | 2021 | 35 | 0.180 |
Why?
|
| Chicago | 5 | 2025 | 808 | 0.180 |
Why?
|
| Milk | 1 | 2021 | 12 | 0.180 |
Why?
|
| Disease Outbreaks | 1 | 2021 | 77 | 0.180 |
Why?
|
| Schistosomiasis | 1 | 2021 | 7 | 0.180 |
Why?
|
| Students | 1 | 2021 | 40 | 0.180 |
Why?
|
| Animal Husbandry | 1 | 2020 | 7 | 0.170 |
Why?
|
| Ethanol | 3 | 2019 | 83 | 0.170 |
Why?
|
| Young Adult | 6 | 2024 | 1721 | 0.170 |
Why?
|
| Macaca mulatta | 1 | 2020 | 46 | 0.170 |
Why?
|
| Phenotype | 1 | 2021 | 254 | 0.170 |
Why?
|
| Weight Gain | 1 | 2020 | 55 | 0.170 |
Why?
|
| Fresh Water | 1 | 2020 | 4 | 0.170 |
Why?
|
| Fatty Acids, Volatile | 4 | 2023 | 28 | 0.170 |
Why?
|
| Microglia | 1 | 2020 | 89 | 0.160 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2020 | 55 | 0.160 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2020 | 72 | 0.160 |
Why?
|
| Trisaccharides | 1 | 2019 | 2 | 0.160 |
Why?
|
| Astronauts | 1 | 2019 | 4 | 0.160 |
Why?
|
| Space Flight | 1 | 2019 | 6 | 0.160 |
Why?
|
| Colonic Polyps | 1 | 2019 | 27 | 0.160 |
Why?
|
| Influenza Vaccines | 1 | 2019 | 11 | 0.160 |
Why?
|
| Mucous Membrane | 1 | 2019 | 25 | 0.160 |
Why?
|
| Specimen Handling | 1 | 2019 | 40 | 0.160 |
Why?
|
| Osteolysis | 1 | 2020 | 135 | 0.160 |
Why?
|
| Prostheses and Implants | 1 | 2020 | 139 | 0.160 |
Why?
|
| Adaptation, Physiological | 1 | 2019 | 43 | 0.160 |
Why?
|
| Firmicutes | 1 | 2019 | 6 | 0.150 |
Why?
|
| Feeding Behavior | 1 | 2019 | 80 | 0.150 |
Why?
|
| Rotenone | 1 | 2018 | 7 | 0.150 |
Why?
|
| Influenza, Human | 1 | 2019 | 41 | 0.150 |
Why?
|
| Adolescent | 5 | 2024 | 1775 | 0.150 |
Why?
|
| Gastrointestinal Diseases | 1 | 2018 | 22 | 0.150 |
Why?
|
| Photoperiod | 2 | 2019 | 30 | 0.150 |
Why?
|
| Parkinsonian Disorders | 1 | 2020 | 149 | 0.150 |
Why?
|
| Tea | 1 | 2018 | 5 | 0.150 |
Why?
|
| Intestinal Mucosa | 2 | 2019 | 144 | 0.150 |
Why?
|
| Mouth Mucosa | 1 | 2018 | 11 | 0.150 |
Why?
|
| Mouth Neoplasms | 1 | 2018 | 19 | 0.150 |
Why?
|
| Obesity | 1 | 2020 | 263 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2018 | 18 | 0.140 |
Why?
|
| Rhinitis, Allergic | 1 | 2018 | 15 | 0.140 |
Why?
|
| Prosthesis-Related Infections | 1 | 2020 | 182 | 0.140 |
Why?
|
| MicroRNAs | 1 | 2018 | 40 | 0.140 |
Why?
|
| Antioxidants | 1 | 2018 | 56 | 0.140 |
Why?
|
| Nose | 1 | 2018 | 36 | 0.140 |
Why?
|
| Asthma | 1 | 2018 | 83 | 0.140 |
Why?
|
| Pilot Projects | 4 | 2020 | 334 | 0.140 |
Why?
|
| Defecation | 1 | 2017 | 6 | 0.140 |
Why?
|
| Dermatitis, Atopic | 1 | 2017 | 13 | 0.140 |
Why?
|
| Microspheres | 1 | 2017 | 21 | 0.140 |
Why?
|
| Phylogeny | 3 | 2025 | 47 | 0.140 |
Why?
|
| Multiple System Atrophy | 1 | 2017 | 25 | 0.130 |
Why?
|
| Rhinitis | 1 | 2018 | 142 | 0.130 |
Why?
|
| Brain | 2 | 2021 | 1324 | 0.130 |
Why?
|
| Bacteremia | 1 | 2017 | 99 | 0.130 |
Why?
|
| Circadian Clocks | 1 | 2016 | 21 | 0.120 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2015 | 50 | 0.110 |
Why?
|
| Alcoholism | 1 | 2015 | 54 | 0.110 |
Why?
|
| alpha-Synuclein | 1 | 2015 | 111 | 0.110 |
Why?
|
| Prospective Studies | 3 | 2024 | 1528 | 0.110 |
Why?
|
| Bacteria, Anaerobic | 1 | 2012 | 1 | 0.100 |
Why?
|
| Middle Aged | 6 | 2025 | 7555 | 0.100 |
Why?
|
| Genital Diseases, Male | 1 | 2012 | 7 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2012 | 47 | 0.100 |
Why?
|
| Time Factors | 3 | 2020 | 1220 | 0.100 |
Why?
|
| Sexual Partners | 2 | 2022 | 17 | 0.090 |
Why?
|
| Staphylococcus aureus | 2 | 2022 | 71 | 0.090 |
Why?
|
| Homosexuality, Male | 2 | 2021 | 24 | 0.090 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2021 | 83 | 0.090 |
Why?
|
| Illinois | 2 | 2021 | 211 | 0.080 |
Why?
|
| Prevalence | 2 | 2021 | 377 | 0.080 |
Why?
|
| Molecular Epidemiology | 2 | 2021 | 27 | 0.080 |
Why?
|
| Carcinogenesis | 2 | 2019 | 22 | 0.080 |
Why?
|
| Chronic Disease | 2 | 2018 | 361 | 0.070 |
Why?
|
| Genome, Bacterial | 2 | 2017 | 13 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 2017 | 55 | 0.060 |
Why?
|
| Genome, Fungal | 1 | 2025 | 3 | 0.060 |
Why?
|
| Whole Genome Sequencing | 1 | 2025 | 8 | 0.060 |
Why?
|
| Child | 2 | 2020 | 990 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 2 | 2017 | 109 | 0.060 |
Why?
|
| Sanitation | 1 | 2024 | 2 | 0.060 |
Why?
|
| Hygiene | 1 | 2024 | 12 | 0.060 |
Why?
|
| Public Health Surveillance | 1 | 2024 | 10 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 236 | 0.050 |
Why?
|
| Public Health | 1 | 2024 | 66 | 0.050 |
Why?
|
| Dextran Sulfate | 1 | 2023 | 8 | 0.050 |
Why?
|
| Schools | 1 | 2023 | 43 | 0.050 |
Why?
|
| Proof of Concept Study | 1 | 2022 | 9 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 70 | 0.050 |
Why?
|
| Travel-Related Illness | 1 | 2021 | 3 | 0.050 |
Why?
|
| Methicillin | 1 | 2021 | 6 | 0.050 |
Why?
|
| Molecular Typing | 1 | 2021 | 10 | 0.050 |
Why?
|
| Pasteurization | 1 | 2021 | 2 | 0.050 |
Why?
|
| Pregnancy | 1 | 2021 | 303 | 0.040 |
Why?
|
| Leptin | 1 | 2020 | 19 | 0.040 |
Why?
|
| Cadherins | 1 | 2020 | 29 | 0.040 |
Why?
|
| Fusobacteria | 1 | 2020 | 2 | 0.040 |
Why?
|
| Anilides | 1 | 2020 | 6 | 0.040 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2020 | 15 | 0.040 |
Why?
|
| Food | 1 | 2020 | 33 | 0.040 |
Why?
|
| Neurotoxins | 1 | 2020 | 10 | 0.040 |
Why?
|
| Glucose | 1 | 2020 | 47 | 0.040 |
Why?
|
| Random Allocation | 1 | 2020 | 114 | 0.040 |
Why?
|
| Pyridines | 1 | 2020 | 27 | 0.040 |
Why?
|
| Lactobacillus | 1 | 2020 | 19 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2020 | 42 | 0.040 |
Why?
|
| Insulin | 1 | 2020 | 75 | 0.040 |
Why?
|
| Waste Disposal, Fluid | 1 | 2020 | 4 | 0.040 |
Why?
|
| Health Personnel | 1 | 2021 | 93 | 0.040 |
Why?
|
| Escherichia coli Proteins | 1 | 2020 | 7 | 0.040 |
Why?
|
| Water Microbiology | 1 | 2020 | 7 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2020 | 89 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 72 | 0.040 |
Why?
|
| Infection Control | 1 | 2021 | 169 | 0.040 |
Why?
|
| Immunity, Mucosal | 1 | 2019 | 10 | 0.040 |
Why?
|
| Period Circadian Proteins | 1 | 2019 | 12 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2020 | 146 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 24 | 0.040 |
Why?
|
| Freezing | 1 | 2019 | 12 | 0.040 |
Why?
|
| Penis | 1 | 2020 | 81 | 0.040 |
Why?
|
| Galactose | 1 | 2019 | 4 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2019 | 63 | 0.040 |
Why?
|
| Th1 Cells | 1 | 2019 | 13 | 0.040 |
Why?
|
| Fructose | 1 | 2019 | 5 | 0.040 |
Why?
|
| United States National Aeronautics and Space Administration | 1 | 2019 | 2 | 0.040 |
Why?
|
| Telomere Homeostasis | 1 | 2019 | 2 | 0.040 |
Why?
|
| Genomic Instability | 1 | 2019 | 9 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 2019 | 13 | 0.040 |
Why?
|
| beta-Lactamases | 1 | 2020 | 91 | 0.040 |
Why?
|
| Cecum | 1 | 2019 | 12 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 13 | 0.040 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2019 | 16 | 0.040 |
Why?
|
| Vaccination | 1 | 2019 | 26 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 174 | 0.040 |
Why?
|
| Solanum tuberosum | 1 | 2019 | 3 | 0.040 |
Why?
|
| DNA Damage | 1 | 2019 | 27 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2021 | 254 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2019 | 21 | 0.040 |
Why?
|
| Rats | 1 | 2020 | 554 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 40 | 0.040 |
Why?
|
| CD3 Complex | 1 | 2018 | 3 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 60 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2019 | 27 | 0.040 |
Why?
|
| Body Weight | 1 | 2019 | 116 | 0.040 |
Why?
|
| Catechin | 1 | 2018 | 2 | 0.040 |
Why?
|
| Gingiva | 1 | 2018 | 2 | 0.040 |
Why?
|
| Streptococcus | 1 | 2018 | 2 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 59 | 0.040 |
Why?
|
| Staphylococcus | 1 | 2018 | 8 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 368 | 0.040 |
Why?
|
| Biomarkers | 1 | 2020 | 453 | 0.040 |
Why?
|
| Epithelium | 1 | 2018 | 17 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 713 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 554 | 0.040 |
Why?
|
| Smokers | 1 | 2018 | 10 | 0.040 |
Why?
|
| Protective Agents | 1 | 2018 | 9 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 22 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2018 | 21 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2018 | 256 | 0.040 |
Why?
|
| Genitalia | 1 | 2017 | 1 | 0.040 |
Why?
|
| Pancreas | 1 | 2018 | 28 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2019 | 138 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 105 | 0.030 |
Why?
|
| South Africa | 1 | 2017 | 11 | 0.030 |
Why?
|
| Constipation | 1 | 2017 | 14 | 0.030 |
Why?
|
| Fermentation | 1 | 2017 | 13 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2017 | 39 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 500 | 0.030 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2017 | 11 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 39 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2017 | 295 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2016 | 16 | 0.030 |
Why?
|
| CLOCK Proteins | 1 | 2016 | 14 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 947 | 0.030 |
Why?
|
| Diet | 1 | 2017 | 199 | 0.030 |
Why?
|
| Infant | 1 | 2017 | 449 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2017 | 489 | 0.030 |
Why?
|
| Protein Folding | 1 | 2015 | 18 | 0.030 |
Why?
|
| Bacterial Translocation | 1 | 2015 | 18 | 0.030 |
Why?
|
| Endotoxemia | 1 | 2015 | 21 | 0.030 |
Why?
|
| Probiotics | 1 | 2015 | 16 | 0.030 |
Why?
|
| Permeability | 1 | 2015 | 87 | 0.030 |
Why?
|
| Risk Factors | 1 | 2020 | 1942 | 0.030 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2015 | 32 | 0.030 |
Why?
|
| Dietary Sucrose | 1 | 2014 | 6 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 12 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 1621 | 0.030 |
Why?
|
| Light | 1 | 2014 | 55 | 0.030 |
Why?
|
| United States | 1 | 2019 | 1726 | 0.030 |
Why?
|
| Cognition | 1 | 2020 | 1104 | 0.030 |
Why?
|
| RNA, Bacterial | 1 | 2012 | 3 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2012 | 34 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2017 | 3062 | 0.020 |
Why?
|
| Aged | 1 | 2015 | 7669 | 0.010 |
Why?
|